JDSRX
Price
$21.75
Change
+$0.10 (+0.46%)
Updated
Dec 20 closing price
VSCAX
Price
$23.41
Change
+$0.25 (+1.08%)
Updated
Dec 20 closing price
Ad is loading...

JDSRX vs VSCAX

Header iconJDSRX vs VSCAX Comparison
Open Charts JDSRX vs VSCAXBanner chart's image
Janus Henderson Small Cap Value R
Price$21.75
Change+$0.10 (+0.46%)
VolumeN/A
CapitalizationN/A
Invesco Small Cap Value A
Price$23.41
Change+$0.25 (+1.08%)
VolumeN/A
CapitalizationN/A
JDSRX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDSRX vs. VSCAX commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDSRX is a Hold and VSCAX is a Hold.

FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.33B vs. JDSRX (1.63B). VSCAX pays higher dividends than JDSRX: VSCAX (0.48) vs JDSRX (0.00). JDSRX was incepted earlier than VSCAX: JDSRX (15 years) vs VSCAX (26 years). VSCAX is a more actively managed with annual turnover of: 51.00 vs. JDSRX (44.00). VSCAX has a lower initial minimum investment than JDSRX: VSCAX (1000) vs JDSRX (2500). VSCAX annual gain was more profitable for investors over the last year : 16.45 vs. JDSRX (-3.96). VSCAX return over 5 years is better than : 65.61 vs. JDSRX (-1.26).
JDSRXVSCAXJDSRX / VSCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years26 years-
Gain YTD-3.95815.647-25%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets1.63B6.33B26%
Annual Yield % from dividends0.000.48-
Returns for 1 year-3.9616.45-24%
Returns for 3 years-9.4133.77-28%
Returns for 5 years-1.2665.61-2%
Returns for 10 years4.1720.4820%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCGO4.510.16
+3.68%
DocGo
VIPS13.580.23
+1.72%
Vipshop Holdings Limited
GOGL8.710.09
+1.04%
Golden Ocean Group Limited
SCHW74.310.69
+0.94%
Charles Schwab Corp (The)
EPIX1.60N/A
N/A
ESSA Pharma